Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m
Lucid Diligence Brief: T-Therapeutics Series A extension to $91m Professional…
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled clinical-trial recruitment
Lucid Diligence Brief: myTomorrows $29 million funding to scale AI-enabled…
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for precision neurology and BCI
Lucid Diligence Brief: INBRAIN and Microsoft partner on agentic AI for…
Lucid Diligence Brief: Galecto acquires Damora Therapeutics
Lucid Diligence Brief: Galecto acquires Damora Therapeutics Professional…
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery
Lucid Diligence Brief: Iambic raises $100M+ for AI drug discovery Professional…
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding
Lucid Diligence Brief: Accipiter Bio $12.7M Seed Funding Professional audiences…
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A
Lucid Diligence Brief: Braveheart Bio launches with $185M Series A Professional…
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing
Lucid Diligence Brief: Azalea Therapeutics launches with $82M financing…
Lucid Diligence Brief: NEOK Bio $75M Series A
Lucid Diligence Brief: NEOK Bio $75M Series A Professional audiences only. Not…
Lucid Diligence Brief: AAVantgarde Bio $141M Series B
Lucid Diligence Brief: AAVantgarde Bio $141M Series B Professional audiences…
Lucid Diligence Brief: Thermo Fisher to acquire Clario
Lucid Diligence Brief: Thermo Fisher to acquire Clario Professional audiences…